The shareholders of Unibios Holdings S.A., after an invitation of the Board of Directors of the company attended a Repeat Extraordinary General Meeting at the Company's Headquarters today 03.03.2023. Those present and represented amounted to 6.4% of the share capital and the meeting was in quorum. Shareholders holding more than one twentieth of the share capital requested the postponement of decisions by this meeting for the 20.03.2023. The proposal was accepted by the President and the assembly will continue in the same place and at the same time (14:00) on 20.03.2023.

The Management of the Company "UNIBIOS HOLDINGS SOCIETE ANONYME" (hereinafter referred to as the "Company"), in accordance with the applicable legislation for the correct, valid and timely information of the investment public, announces that it intends to sell up to 150,000 own shares it holds, which correspond to 0.96% of its paid-up share capital.

The sale of the above own shares will take place through a private placement.

Please, see attached announcement.

AthexClear S.A.

AthexClear, as the Clearing Fund Administrator, in accordance with Part 6, Section II of Derivatives Clearing Rulebook, announces that the Derivatives Clearing Fund is set to € 17,163,581.00 for March 2023.

AthexClear S.A.

AthexClear, as the Clearing Fund Administrator, in accordance with Part 5, Section II of Securities Clearing Rulebook, announces that the Securities Clearing Fund is set to € 21,747,936.00 for March 2023.

Attached